Literature DB >> 12740374

Molecular interaction and enzymatic activity of macrophage migration inhibitory factor with immunorelevant peptides.

Ilaria Potolicchio1, Laura Santambrogio, Jack L Strominger.   

Abstract

Disulfide reduction is an important step in antigen processing for HLA class II restricted T cell responses. Migration inhibitory factor (MIF) is a member of the thioredoxin family and has been classically defined as a cytokine. Using enzyme-linked immunosorbent assay and CD analysis, here we describe the binding to MIF of two peptides, hepatitis B surface antigen (HBsAg) and insulin B (InsB) with high affinity for HLA class II allo-types, HLA-DP2 and HLA-DQ8, respectively. At neutral pH, cysteinylated InsB was a substrate for MIF thiol reductase activity, as assessed by mass spectroscopy/electrospray analysis. Finally, a biologically active form of MIF co-immunopurified with mature forms of HLA DP2/15, and a peptide derived from the HLA-DP beta1 helix could be used for affinity purification of MIF. The possibility that MIF participates in class II antigen presentation and/or as a chaperone is discussed.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12740374     DOI: 10.1074/jbc.M302854200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  8 in total

1.  Amplification of tumor hypoxic responses by macrophage migration inhibitory factor-dependent hypoxia-inducible factor stabilization.

Authors:  Millicent Winner; Albert C Koong; Beatriz E Rendon; Wayne Zundel; Robert A Mitchell
Journal:  Cancer Res       Date:  2007-01-01       Impact factor: 12.701

2.  Characterization of a Plasmodium falciparum macrophage-migration inhibitory factor homologue.

Authors:  Damien V Cordery; Uday Kishore; Sue Kyes; Mohammed J Shafi; Katherine R Watkins; Thomas N Williams; Kevin Marsh; Britta C Urban
Journal:  J Infect Dis       Date:  2007-02-01       Impact factor: 5.226

3.  Effect of macrophage migration inhibitory factor (MIF) gene variants and MIF serum concentrations on the risk of type 2 diabetes: results from the MONICA/KORA Augsburg Case-Cohort Study, 1984-2002.

Authors:  C Herder; N Klopp; J Baumert; M Müller; N Khuseyinova; C Meisinger; S Martin; T Illig; W Koenig; B Thorand
Journal:  Diabetologia       Date:  2007-08-22       Impact factor: 10.122

4.  Homotrimeric macrophage migration inhibitory factor (MIF) drives inflammatory responses in the corneal epithelium by promoting caveolin-rich platform assembly in response to infection.

Authors:  Thomas Reidy; Alexander Rittenberg; Markryan Dwyer; Samantha D'Ortona; Gerald Pier; Mihaela Gadjeva
Journal:  J Biol Chem       Date:  2013-01-31       Impact factor: 5.157

5.  Further evidence for increased macrophage migration inhibitory factor expression in prostate cancer.

Authors:  Katherine L Meyer-Siegler; Kenneth A Iczkowski; Pedro L Vera
Journal:  BMC Cancer       Date:  2005-07-06       Impact factor: 4.430

6.  Substance P induces localization of MIF/alpha1-inhibitor-3 complexes to umbrella cells via paracellular transit through the urothelium in the rat bladder.

Authors:  Pedro L Vera; Katherine L Meyer-Siegler
Journal:  BMC Urol       Date:  2006-09-18       Impact factor: 2.264

7.  Upregulation of the TRPA1 Ion Channel in the Gastric Mucosa after Iodoacetamide-Induced Gastritis in Rats: A Potential New Therapeutic Target.

Authors:  Kata Csekő; Dániel Pécsi; Béla Kajtár; Ivett Hegedűs; Alexander Bollenbach; Dimitrios Tsikas; Imre László Szabó; Sándor Szabó; Zsuzsanna Helyes
Journal:  Int J Mol Sci       Date:  2020-08-05       Impact factor: 5.923

8.  Immunity and mental illness: findings from a Danish population-based immunogenetic study of seven psychiatric and neurodevelopmental disorders.

Authors:  Ron Nudel; Michael E Benros; Morten Dybdahl Krebs; Rosa Lundbye Allesøe; Camilla Koldbæk Lemvigh; Jonas Bybjerg-Grauholm; Anders D Børglum; Mark J Daly; Merete Nordentoft; Ole Mors; David M Hougaard; Preben Bo Mortensen; Alfonso Buil; Thomas Werge; Simon Rasmussen; Wesley K Thompson
Journal:  Eur J Hum Genet       Date:  2019-04-11       Impact factor: 4.246

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.